Project Grant U9055833
- The Department of Health and Human Services Health Resources and Services Administration awarded the University of Missouri-Kansas City $1,289,979 under the Special Projects of National Significance (SPNS) program on September 1, 2026, to serve as the national evaluation provider for HRSA's 2026–2029 SPNS initiative on strategies to link, engage, and retain men with HIV in care. The recipient will conduct a rigorous, practical, multi-site implementation science evaluation of intervention...
- The Department of Health and Human Services Health Resources and Services Administration awarded $2.081 million to Positive Impact Health Centers Inc. on October 1, 2025, under the Ryan White Part C Outpatient EIS Program (CFDA 93.145, HIV-Related Training and Technical Assistance). The award funds early intervention services and technical assistance delivery for HIV care and treatment through April 30, 2028, with place of performance in Atlanta, Georgia. Positive Impact Health Centers Inc., a...
- The Health Resources and Services Administration awarded Cicatelli Associates, Inc., a $1.5 million Project Grant on April 1, 2026, under the HIV Emergency Relief Project Grants program (CFDA 93.914) to deliver national training and technical assistance to Ryan White HIV/AIDS Program (RHWAP) recipients in eight non-Ending the Epidemic states. CAI will collaborate with HRSA to identify and engage eight non-EHE states with unmet need among populations disproportionately impacted by HIV who are out...
- The National Institute on Drug Abuse awarded Emory University $175,625 on August 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and pilot comprehensive implementation strategies supporting delivery of a peer bridge model targeting people with HIV who have substance use disorders in emergency departments. The project addresses a syndemic of substance use disorder, intimate partner violence, and HIV by integrating screening, brief intervention, and referral...
- The National Institute of Mental Health awarded Emory University $781,081 on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct the Pharmacy-Based LAI ART Versus Clinic Effectiveness (PLACE) study, a five-year research project examining long-acting injectable antiretroviral therapy delivery through pharmacies as an alternative to HIV clinics. The study addresses retention and viral suppression barriers in HIV treatment, particularly racial inequities...
- The Department of Health and Human Services National Institutes of Health Fogarty International Center awarded Partnership For Research And Action For Health $192,292 on April 1, 2026, under the International Research and Research Training program (CFDA 93.989) to reduce HIV testing barriers and stigma among men who have sex with men in Georgia. The award funds adaptation and pilot testing of evidence-based digital health interventions developed from prior randomized controlled trials. The...
- The National Institute of Allergy and Infectious Diseases awarded Emory University $1.273 million on June 2, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct the MISTR+ study, which develops and tests low-touch interventions to improve telehealth HIV preexposure prophylaxis (PrEP) initiation, retention, and re-engagement outcomes among over 100,000 users of telemedicine PrEP services. The project will develop a series of evidence-based, low-cost...
- The Department of Health and Human Services National Institutes of Health Fogarty International Center awarded Emory University $201,355 on June 1, 2026, under the International Research and Research Training program (CFDA 93.989) to strengthen HIV-associated non-communicable disease research capacity in Mozambican prisons. Emory will integrate screening for five prioritized non-communicable diseases—smoking, substance use disorders, depression, hypertension, and malnutrition—into mass TB...
- Federal Grant Award Summary UT Southwestern Medical Center received a $150,000 project grant from the Health Resources and Services Administration's HIV/AIDS Bureau under the HIV-Related Training and Technical Assistance program (CFDA 93.145) for the period of September 1, 2025, through August 31, 2026. Under this award, UT Southwestern's Dallas Family Access Network (DFAN) Engage Initiative, led by Dr. Jeremy Chow, will deliver community-based outreach and capacity-building services to...
- This $1,272,341 cooperative agreement from the Centers for Disease Control and Prevention will support efforts to promote pre-exposure prophylaxis (PrEP) adherence among men who have sex with men of color. Awarded under the HIV Demonstration, Research, Public and Professional Education Projects program (CFDA 93.941), the University of North Carolina at Chapel Hill will work to develop and test improved HIV prevention strategies from September 2021 through October 2022. A subaward of $250,000...
The Health Resources and Services Administration HIV/AIDS Bureau awarded Emory University $3.24 million on September 1, 2026, under the Special Projects of National Significance program (CFDA 93.928) to serve as implementation technical assistance provider for the REACH Men initiative. REACH Men will deliver intensive technical assistance, organizational development support, implementation coaching, continuous quality improvement, and peer learning to eight Ryan White HIV/AIDS Program-funded implementation sites nationwide serving men with HIV. The initiative targets men newly diagnosed, returning to care after prolonged disengagement, lacking infrastructure to maintain care engagement, or facing complex barriers such as transitioning from incarceration or experiencing homelessness. Emory will employ an integrated implementation approach combining capacity building, facilitation components of I-PARIHS, the HAB Implementation Framework including Ryan White Program Moving Forward, and the DIAL continuous quality improvement framework to teach, implement, and refine promising intervention strategies. Emory will collaborate with the HRSA HIV/AIDS Bureau and an evaluation provider to identify effective strategies addressing persistent gaps in HIV care engagement, retention, and viral suppression among men with HIV, supported by an advisory board. Place of performance is Atlanta, Georgia. The period of performance runs from September 1, 2026, through August 31, 2029. The assistance type is a Project Grant.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $3.2m | 8/24/26 |